Real-world breast cancer care under the microscope in russia
NCT ID NCT04943497
First seen Jan 10, 2026 · Last updated May 16, 2026 · Updated 25 times
Summary
This study observed over 2,400 women in Russia with a certain type of advanced breast cancer (HR+/HER2-). Researchers tracked which treatments doctors chose (like ribociclib, alpelisib, hormone therapy, or chemo) and how long they worked before needing a change. The goal was to understand real-world treatment patterns and outcomes, not to test a new drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Syktyvkar, Komi, 167904, Russia
-
Novartis Investigative Site
Sochi, Russian Federation, 354057, Russia
-
Novartis Investigative Site
Kaluga, Russia, 248007, Russia
-
Novartis Investigative Site
Surgut, Tymen Area, 628402, Russia
-
Novartis Investigative Site
Arkhangelsk, 163045, Russia
-
Novartis Investigative Site
Barnaul, 656045, Russia
-
Novartis Investigative Site
Belgorod, 308010, Russia
-
Novartis Investigative Site
Bryansk, 241028, Russia
-
Novartis Investigative Site
Cheboksary, 428020, Russia
-
Novartis Investigative Site
Chelyabinsk, 454087, Russia
-
Novartis Investigative Site
Cherkessk, 369000, Russia
-
Novartis Investigative Site
Chita, 672027, Russia
-
Novartis Investigative Site
Irkutsk, 664035, Russia
-
Novartis Investigative Site
Ivanovo, 153040, Russia
-
Novartis Investigative Site
Izhevsk, 426009, Russia
-
Novartis Investigative Site
Kaliningrad, 236016, Russia
-
Novartis Investigative Site
Khabarovsk, 680042, Russia
-
Novartis Investigative Site
Khanty-Mansiysk, 628012, Russia
-
Novartis Investigative Site
Kirov, 610021, Russia
-
Novartis Investigative Site
Kostroma, 156005, Russia
-
Novartis Investigative Site
Krasnodar, 350040, Russia
-
Novartis Investigative Site
Krasnoyarsk, 660022, Russia
-
Novartis Investigative Site
Moscow, 105005, Russia
-
Novartis Investigative Site
Moscow, 111123, Russia
-
Novartis Investigative Site
Moscow, 115304, Russia
-
Novartis Investigative Site
Moscow, 115522, Russia
-
Novartis Investigative Site
Moscow, 129110, Russia
-
Novartis Investigative Site
Moscow, 143423, Russia
-
Novartis Investigative Site
Moscow Region Balas, 143900, Russia
-
Novartis Investigative Site
Nal'chik, 360051, Russia
-
Novartis Investigative Site
Nizhny Novgorod, 603081, Russia
-
Novartis Investigative Site
Novosibirsk, 630108, Russia
-
Novartis Investigative Site
Odintsovo, 143003, Russia
-
Novartis Investigative Site
Omsk, 644013, Russia
-
Novartis Investigative Site
Perm, 614066, Russia
-
Novartis Investigative Site
Podolsk, 142110, Russia
-
Novartis Investigative Site
Pyatigorsk, 357502, Russia
-
Novartis Investigative Site
Rostov-on-Don, 344006, Russia
-
Novartis Investigative Site
Saint Petersburg, 191104, Russia
-
Novartis Investigative Site
Saint Petersburg, 194214, Russia
-
Novartis Investigative Site
Saint Petersburg, 197758, Russia
-
Novartis Investigative Site
Saransk, 430032, Russia
-
Novartis Investigative Site
Saratov, 410053, Russia
-
Novartis Investigative Site
Sestroretsk, 197706, Russia
-
Novartis Investigative Site
Sevastopol’, 299045, Russia
-
Novartis Investigative Site
Severodvinsk, 450054, Russia
-
Novartis Investigative Site
Simferopol, 295023, Russia
-
Novartis Investigative Site
Tambov, 392000, Russia
-
Novartis Investigative Site
Tula, 300040, Russia
-
Novartis Investigative Site
Tver', 170008, Russia
-
Novartis Investigative Site
Tyumen, 625041, Russia
-
Novartis Investigative Site
Ufa, 450054, Russia
-
Novartis Investigative Site
Vladikavkaz, 362002, Russia
-
Novartis Investigative Site
Vladivostok, 690105, Russia
-
Novartis Investigative Site
Voronezh, 394036, Russia
-
Novartis Investigative Site
Yekaterinburg, 620027, Russia
-
Novartis Investigative Site
Yekaterinburg, 620036, Russia
-
Novartis Investigative Site
Yuzhno-Sakhalinsk, 693010, Russia
Conditions
Explore the condition pages connected to this study.